Panzer reported Q4 revenue of $700,000 from R&D services and a “small gross margin gain.” Total operating expenses were $15 million, and the net loss was $13.2 million. For the full year 2025, revenue ...

Madison Investments, an investment advisor, released its fourth-quarter 2025 investor letter for the “Madison Large Cap Fund” ...

Good day, and thank you for standing by. Welcome to the Diamondback Energy's Fourth Quarter 2025 Conference Call. [Operator Instructions] Please be advised that today's conference call is being ...

Operating capital runway sufficient into the fourth quarter of 2026 In-person Type C FDA meeting scheduled by end of the first quarter of 2026 to ...

While it doesn’t have the signature zipper making this sweater a quarter-zip, the button-up silhouette is very similar and super stylish. Coming in a creamy, natural color, this lightweight top is ...

ICU Medical, Inc. (NASDAQ:ICUI) Q4 2025 Earnings Call Transcript February 20, 2026 Operator: Good day, and welcome to the ICU ...

Insmed Incorporated (NASDAQ:INSM) Q4 2025 Earnings Call Transcript February 19, 2026 Insmed Incorporated misses on earnings ...

An error has occurred. Please try again. With a Lewiston Sun Journal subscription, you can gift 5 articles each month. It looks like you do not have any active ...

Missouri women’s basketball stayed competitive early but could not recover from a disastrous second quarter as Georgia pulled away for an 85-66 win Sunday at Mizzou Arena, snapping the Tigers’ ...

Affirm Holdings, Inc. (NASDAQ: AFRM) (“Affirm” or the “Company”) today reported financial results for its fiscal 2026 second quarter ended December 31, 2025. The results, which include a shareholder ...

The company’s new ASTRO N7 Pro PV modules achieve 2% higher cumulative energy yield over the project lifecycle compared to conventional previous-generation modules, according to Astronergy Head of ...

Company experiencing strong demand in the U.S. following FDA marketing authorization of ProSense® as the only on-label minimally invasive solution for the local treatment of low-risk breast cancer, ...